Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Clinical trial NCT05569772 · RECRUITING

Trial details

NCT number: NCT05569772
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glucose Intolerance After a Recent History of Gestational Diabetes

Start date: 2023-09-14
Primary completion: 2029-06-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.